3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
20
Fatigue
16
Neoplasms
8
Depression
6
Pain
5
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Vomiting
2
Sleep Wake Disorders
2
Sleep Initiation and Maintenance Disorders
2
Rectal Neoplasms
2
Polycystic Ovary Syndrome
2
Parasomnias
2
Oligodendroglioma
2
Obesity
2
Nausea
2
Motor Activity
2
Meningioma
2
Medulloblastoma
2
Lymphedema
2
Leukemia
2
Head and Neck Neoplasms
2
Gliosarcoma
2
Glioblastoma
2
Ependymoma
2
Interventions
Transcranial Magnetic Stimulation
2
Lidocaine
2
Yoga
1
Transcutaneous Electric Nerve Stimulation
1
Surveys and Questionnaires
1
Spinal Cord Stimulation
1
Sodium Chloride
1
Radiofrequency Ablation
1
Pregabalin
1
Manipulation, Osteopathic
1
Low-Level Light Therapy
1
Ketamine
1
Hypnosis
1
Hospitals
1
Exercise Therapy
1
Exercise
1
Electroacupuncture
1
Cryosurgery
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neuralgia
×
Yoga
×
Clear all
NCT05121558
2026-02-06
YCT
Dana-Farber Cancer Institute
Phase NA
Active not recruiting
227 enrolled